The global Breast Cancer Diagnostics Market is valued at USD 19.43 Billion in 2024 and is projected to reach a value of USD ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

At the moment, Swiss Re’s underwriting performance is not looking the best among peers. Swiss Re has sound financial health. Swiss Re holds $8.5 billion of debt on its balance sheet. $1.0 billion of ...